Pivotal trial of OPA-15406

Trial Profile

Pivotal trial of OPA-15406

Planning
Phase of Trial: Phase III

Latest Information Update: 07 Sep 2017

At a glance

  • Drugs OPA 15406 (Primary)
  • Indications Atopic dermatitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Medimetriks Pharmaceuticals
  • Most Recent Events

    • 07 Sep 2017 New trial record
    • 06 Sep 2017 According to a Medimetriks Pharmaceuticals media release, this trial is expected to begin in the first quarter of 2018 with a goal of filing an NDA in the second half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top